Search form



CL Mobile Menu


Drug Offers Novel Approach for Airway Diseases

For patients with asthma or COPD, PL554 has the potential to both reverse bronchodilation and reduce inflammation more quickly and with fewer adverse effects.


A recent literature review found that up to 90% of COPD patients experience ADL-limiting morning symptoms.

Results of a new study suggest that racial inequalities in COPD, especially in women, may be shaped by socioeconomic factors.

The Breathlessness, Cough and Sputum Scale, used to evaluate COPD treatment efficacy, may help predict exacerbations in severe disease.

The CASCADE study found the biomarker of inflammation CRP associated with higher COPD symptom burden.

A new study sought to clarify conflicting findings on the impact of supplemental oxygen on exacerbations, hospitalization, and quality of life.

A new 5-question COPD assessment tool may help identify more serious disease earlier in the primary care setting.

The combination of heat and in-home air pollutants is dangerous, but also modifiable, say authors of a new study.


Subscribe to COPD on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.